Anebulo Pharmaceuticals Statistics

Total Valuation

ANEB has a market cap or net worth of $55.88 million. The enterprise value is $40.88 million.

Market Cap	55.88M
Enterprise Value	40.88M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ANEB has 41.08 million shares outstanding. The number of shares has increased by 2.48% in one year.

Current Share Class	41.08M
Shares Outstanding	41.08M
Shares Change (YoY)	+2.48%
Shares Change (QoQ)	+5.72%
Owned by Insiders (%)	40.54%
Owned by Institutions (%)	3.75%
Float	3.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.73
P/TBV Ratio	3.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.52

Current Ratio	17.52
Quick Ratio	17.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.52

Financial Efficiency

Return on equity (ROE) is -71.49% and return on invested capital (ROIC) is -46.65%.

Return on Equity (ROE)	-71.49%
Return on Assets (ROA)	-42.87%
Return on Invested Capital (ROIC)	-46.65%
Return on Capital Employed (ROCE)	-53.50%
Revenue Per Employee	n/a
Profits Per Employee	-$2.56M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.08% in the last 52 weeks. The beta is -1.09, so ANEB's price volatility has been lower than the market average.

Beta (5Y)	-1.09
52-Week Price Change	-51.08%
50-Day Moving Average	1.45
200-Day Moving Average	1.80
Relative Strength Index (RSI)	45.57
Average Volume (20 Days)	53,373

Short Selling Information

The latest short interest is 54,738, so 0.13% of the outstanding shares have been sold short.

Short Interest	54,738
Short Previous Month	62,352
Short % of Shares Out	0.13%
Short % of Float	1.61%
Short Ratio (days to cover)	1.94

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.00M
Pretax Income	-9.35M
Net Income	-7.67M
EBITDA	n/a
EBIT	-8.00M
Earnings Per Share (EPS)	-$0.29

Full Income Statement

Balance Sheet

The company has $15.00 million in cash and n/a in debt, giving a net cash position of $15.00 million or $0.37 per share.

Cash & Cash Equivalents	15.00M
Total Debt	n/a
Net Cash	15.00M
Net Cash Per Share	$0.37
Equity (Book Value)	14.96M
Book Value Per Share	0.36
Working Capital	14.52M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.65M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ANEB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.48%
Shareholder Yield	n/a
Earnings Yield	-13.72%
FCF Yield	n/a

Analyst Forecast

The average price target for ANEB is $8.00, which is 488.24% higher than the current price. The consensus rating is "Buy".

Price Target	$8.00
Price Target Difference	488.24%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2